Heart Disease News and Research

Latest Heart Disease News and Research

ChanTest announces Phase II SBIR grant to optimize cardiomyocyte-based assays

ChanTest, the leading CRO expert in ion channels and nonclinical cardiac safety testing, announces funding of a Phase II SBIR grant. ChanTest will use the grant from the National Heart Lung & Blood Institute to optimize drug safety and discovery assays using stem cell-derived human cardiomyocytes

18 Sep 2012

Bariatric surgery reduces long-term risk of diabetes by over 80% among people with obesity

Bariatric surgery reduces the long-term risk of developing diabetes by over 80% among people with obesity. The New England Journal of Medicine (NEJM) has published the results of a study conducted at Sahlgrenska Academy, University of Gothenburg, Sweden.

18 Sep 2012

Fall prediction and prevention technology: an interview with Rob Goudswaard and Heribert Baldus from Philips

Falls in the elderly are a major health problem. It is has emerged from data in the US that roughly 1 in 3 people over 65 fall at least once a year. Half of them experience the same again the next year.

18 Sep 2012

Cancer surpasses heart disease as leading cause of death among U.S. Hispanics

A new report from American Cancer Society researchers finds that despite declining death rates, cancer has surpassed heart disease as the leading cause of death among Hispanics in the U.S. In 2009, the most recent year for which actual data are available, 29,935 people of Hispanic origin in the U.S. died of cancer, compared to 29,611 deaths from heart disease.

18 Sep 2012

Researchers to probe causes, treatments of toxic reactions in blood plasma

In the largest undertaking of its kind, scientists at four leading U.S. research institutions are embarking upon a five-year National Institutes of Health (NIH)-funded study to make blood transfusions safer and more effective by uncovering the exact causes of hemoglobin toxicity.

18 Sep 2012

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

Pfizer Oncology today announced that important data from its lung cancer and renal cell carcinoma (RCC) portfolios will be presented at the upcoming European Society for Medical Oncology (ESMO) Congress in Vienna, Austria, September 28 - October 2, 2012.

18 Sep 2012

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Group A Streptococcus on the illumigene platform.

18 Sep 2012

HSS recognizes Kaiser Permanente Colorado as a 2012 Hypertension Control Champion

Today, U.S. Department of Health and Human Services Secretary Kathleen Sebelius recognized Kaiser Permanente Colorado as a 2012 Million Hearts Hypertension Control Champion. Million Hearts is a national public-private initiative of the U.S. Department of Health and Human Services.

18 Sep 2012

Sentara Heart Hospital performs first innovative Atrial Fibrillation procedure

Sentara Heart Hospital is leading the way in an innovative Atrial Fibrillation (AF) procedure for what is typically the most difficult to treat or persistent, forms of AF. This past week, surgeons and cardiologists at Sentara Heart Hospital were the first in the world to begin performing surgeries in the Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study (Staged DEEP) feasibility trial.

18 Sep 2012

Renal denervation given the thumbs up by researchers

Catheter-based renal denervation is a cost-effective strategy for resistant hypertension that may result in lower cardiovascular morbidity and mortality, a modeling prediction suggests.

17 Sep 2012

Refinements in gene therapy prove beneficial for ‘bubble babies’

Results from a long-term study published in Blood show that adding a low dose of chemotherapy prior to gene therapy can help improve outcomes in children with adenosine deaminase-deficient severe combined immunodeficiency.

17 Sep 2012

Type 2 diabetes mellitus patients are at increased risk for cardiovascular disease

LipoScience, Inc., a highly innovative diagnostic company that is advancing patient care by developing high value proprietary blood tests using nuclear magnetic resonance technology, today announced the publication of results from a clinical study in the American Journal of Cardiology suggesting that despite having cholesterol levels considered acceptable by today's clinical standards, patients with Type 2 diabetes mellitus (T2DM) are at increased risk for cardiovascular disease-related events.

17 Sep 2012

NIH awards ASC grant to study ASC-101-treated amniotic fluid-derived stem cells in compartment syndrome

America Stem Cell, Inc. today announced that it has been awarded an Advanced Technology Small Business Technology Transfer Research (STTR) grant from the National Heart Lung and Blood Institute at the National Institutes of Health.

17 Sep 2012

vasopharm's explorative phase IIa NOSTRA trial in TBI meets clinical endpoints for safety

vasopharm GmbH, a pharmaceutical company dedicated to the discovery and development of novel therapeutics for the treatment of cerebro- and cardiovascular diseases, today announces that the explorative phase IIa NOSTRA trial in Traumatic Brain Injury Patients met all clinical endpoints for safety and in addition demonstrated strong evidence of clinical benefit in patients.

17 Sep 2012

Health law complexities create challenges for Va. Senate candidates

The Washington Post reports on how the challenges surrounding the implementation of the overhaul are leading Senate candidates in Virginia to some nuanced positions. Meanwhile, Kaiser Health News tracked weekend news coverage of statement by House Minority Leader Nancy Pelosi on why she thinks the GOP position on Medicare will help Democrats take back the House.

17 Sep 2012

Researchers investigate African plants effective in treating snakebite

A PhD student at the University of Copenhagen has drawn on nature's own pharmacy to help improve the treatment of snakebites in Africa.

17 Sep 2012

Risks of antidiabetic drug substantially overrated for patients with reduced kidney function

The antidiabetic drug metformin is not prescribed for patients with reduced kidney function because the risk of adverse effects has been regarded as unacceptably high. A study at Sahlgrenska Academy, University of Gothenburg, Sweden, has found that the risks have been substantially overrated. As a result, many more patients with diabetes may be able to enjoy the benefits of the medication.

17 Sep 2012

First Edition: September 17, 2012

Today's headlines include a number of reports about how Medicare and other health policy issues are playing important roles on the campaign trail.

17 Sep 2012

Cardiovascular mortality in Brazil has increased 3.5 times more than in other developing countries

Despite Brazil's successful prevention campaigns which have contributed to a reduction in risk factors such as smoking, cardiovascular disease (CVD) remains the first cause of death in the country, at 32%. Tobacco consumption and decrease of salt in local diets are some of the risk factors that will be discussed at the 67th Annual Congress of the Brazilian Society of Cardiology which takes place in Recife, Brazil from 14 to 17 September 2012.

15 Sep 2012

Scientists identify genetic building blocks behind human heart's subtle control system

Since the early 1900s, scientists have been wondering how birds and mammals could have developed almost identical conduction systems independently of each other when their common ancestor was a cold-blooded reptile with a sponge-like inner heart that has virtually no conduction bundles.

15 Sep 2012

Heart Disease News and Research

Latest Heart Disease News and Research

ChanTest announces Phase II SBIR grant to optimize cardiomyocyte-based assays

Bariatric surgery reduces long-term risk of diabetes by over 80% among people with obesity

Fall prediction and prevention technology: an interview with Rob Goudswaard and Heribert Baldus from Philips

Cancer surpasses heart disease as leading cause of death among U.S. Hispanics

Researchers to probe causes, treatments of toxic reactions in blood plasma

Important data from Pfizer’s lung cancer and RCC portfolios to be presented at ESMO Congress

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

HSS recognizes Kaiser Permanente Colorado as a 2012 Hypertension Control Champion

Sentara Heart Hospital performs first innovative Atrial Fibrillation procedure

Renal denervation given the thumbs up by researchers

Refinements in gene therapy prove beneficial for ‘bubble babies’

Type 2 diabetes mellitus patients are at increased risk for cardiovascular disease

NIH awards ASC grant to study ASC-101-treated amniotic fluid-derived stem cells in compartment syndrome

vasopharm's explorative phase IIa NOSTRA trial in TBI meets clinical endpoints for safety

Health law complexities create challenges for Va. Senate candidates

Researchers investigate African plants effective in treating snakebite

Risks of antidiabetic drug substantially overrated for patients with reduced kidney function

First Edition: September 17, 2012

Cardiovascular mortality in Brazil has increased 3.5 times more than in other developing countries

Scientists identify genetic building blocks behind human heart's subtle control system

Industry Focus: Cell & Gene Therapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Heart Disease News and Research

Latest Heart Disease News and Research

Industry Focus: Cell & Gene Therapy eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in